Medical Facilities (FRA:31F) Research & Development: €0.0 Mil (TTM As of Mar. 2026)


FRA:31F Medical Facilities Corp FRA:31F
72 GF Score
Price €10.90
GF Value €8.94
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Medical Facilities Research & Development?

Medical Facilities FRA:31F -0.91% 72 Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:31F with a GF Score™ of 72/100 and a GF Value™ of €8.94 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Medical Facilities's Research & Development for the three months ended in Mar. 2026 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0.0 Mil.

Medical Facilities  (FRA:31F) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medical Facilities Research & Development Related Terms

Medical Facilities Research & Development Historical Data

* Premium members only.

The historical data trend for Medical Facilities's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Facilities Research & Development Chart

Medical Facilities Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medical Facilities Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:31F
72GF Score
Medical Facilities Corp FRA:31F
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Facilities Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Medical Facilities (FRA:31F) has a Research & Development of €0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Medical Facilities and its competitors.
Is Medical Facilities' Research & Development too high?
Medical Facilities' current Research & Development is €0.0 Mil. Overall, Medical Facilities has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medical Facilities' Research & Development compare to HCA and THC?
Medical Facilities' Research & Development of €0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Medical Facilities and its competitors. Medical Facilities's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Facilities stock overvalued right now?
Based on GuruFocus' analysis, Medical Facilities (FRA:31F) is currently considered Modestly Overvalued. The stock's GF Value™ is €8.94, compared to a current price of €10.90 — trading 21.9% above its estimated fair value. The current Research & Development is €0.0 Mil. Medical Facilities' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Medical Facilities (FRA:31F), the current Research & Development is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Facilities (FRA:31F) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Facilities stock appears to be overvalued. The current stock price of €10.90 is trading 21.9% above its estimated GF Value™ of €8.94. GuruFocus considers Medical Facilities to be Modestly Overvalued.

Key valuation signals for FRA:31F:

  • Research & Development: €0.0 Mil
  • GF Value™: €8.94 vs. price of €10.90 (21.9% above fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:31F stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Facilities Business Description

Other Exchanges MFCSF:USADR:Canada
Address 4576 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6N4
Medical Facilities Corp owns a diverse portfolio of surgical facilities in the United States. Through its wholly-owned subsidiaries, the company owns controlling interests in three specialty surgical hospitals. The hospitals offer a range of non-emergency surgical, diagnostic imaging, pain management procedures, and other ancillary services.
72GF Score

Get the complete analysis for FRA:31F

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.90
Price
€8.94
GF Value